These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 17159813

  • 1. Opioid-binding protein/cell adhesion molecule-like (OPCML) gene and promoter methylation status in women with ovarian cancer.
    Czekierdowski A, Czekierdowska S, Szymanski M, Wielgos M, Kaminski P, Kotarski J.
    Neuro Endocrinol Lett; 2006 Oct; 27(5):609-13. PubMed ID: 17159813
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Correlations of CpG island methylator phenotype and OPCML gene methylation to carcinogenesis of hepatocellular carcinoma].
    Liu WJ, Wang L, Wang JP, Li JQ, Zhang CQ, Zheng L, Yuan YF.
    Ai Zheng; 2006 Jun; 25(6):696-700. PubMed ID: 16764763
    [Abstract] [Full Text] [Related]

  • 5. OPCML gene promoter methylation and gene expression in tumor and stroma cells of invasive cervical carcinoma.
    Ye F, Zhang SF, Xie X, Lu WG.
    Cancer Invest; 2008 Jul; 26(6):569-74. PubMed ID: 18584347
    [Abstract] [Full Text] [Related]

  • 6. Microvessel density and CpG island methylation of the THBS2 gene in malignant ovarian tumors.
    Czekierdowski A, Czekierdowska S, Danilos J, Czuba B, Sodowski K, Sodowska H, Szymanski M, Kotarski J.
    J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():53-65. PubMed ID: 18955754
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of opioid binding protein/cell adhesion molecule-like promoter methylation in bladder carcinoma.
    Duarte-Pereira S, Paiva F, Costa VL, Ramalho-Carvalho J, Savva-Bordalo J, Rodrigues A, Ribeiro FR, Silva VM, Oliveira J, Henrique R, Jerónimo C.
    Eur J Cancer; 2011 May; 47(7):1106-14. PubMed ID: 21273058
    [Abstract] [Full Text] [Related]

  • 8. Frequent inactivation of a putative tumor suppressor, angiopoietin-like protein 2, in ovarian cancer.
    Kikuchi R, Tsuda H, Kozaki K, Kanai Y, Kasamatsu T, Sengoku K, Hirohashi S, Inazawa J, Imoto I.
    Cancer Res; 2008 Jul 01; 68(13):5067-75. PubMed ID: 18593905
    [Abstract] [Full Text] [Related]

  • 9. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W, Marquez RT, Lu Z, Liu J, Lu KH, Issa JP, Fishman DM, Yu Y, Bast RC.
    Cancer; 2008 Apr 01; 112(7):1489-502. PubMed ID: 18286529
    [Abstract] [Full Text] [Related]

  • 10. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J, Bektas N, Hartmann A, Kristiansen G, Heindrichs U, Knüchel R, Dahl E.
    Breast Cancer Res; 2008 Apr 01; 10(5):R82. PubMed ID: 18826564
    [Abstract] [Full Text] [Related]

  • 11. BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.
    Baldwin RL, Nemeth E, Tran H, Shvartsman H, Cass I, Narod S, Karlan BY.
    Cancer Res; 2000 Oct 01; 60(19):5329-33. PubMed ID: 11034065
    [Abstract] [Full Text] [Related]

  • 12. Methylation of OPCML promoter in ovarian cancer tissues predicts poor patient survival.
    Zhou F, Tao G, Chen X, Xie W, Liu M, Cao X.
    Clin Chem Lab Med; 2014 May 01; 52(5):735-42. PubMed ID: 24327526
    [Abstract] [Full Text] [Related]

  • 13. [Hypermethylation of promoter region of RASSF1A gene in ovarian malignant epithelial tumors].
    Ma L, Zhang JH, Liu FR, Zhang X.
    Zhonghua Zhong Liu Za Zhi; 2005 Nov 01; 27(11):657-9. PubMed ID: 16438885
    [Abstract] [Full Text] [Related]

  • 14. Methylation and messenger RNA expression of p15INK4b but not p16INK4a are independent risk factors for ovarian cancer.
    Liu Z, Wang LE, Wang L, Lu KH, Mills GB, Bondy ML, Wei Q.
    Clin Cancer Res; 2005 Jul 01; 11(13):4968-76. PubMed ID: 16000597
    [Abstract] [Full Text] [Related]

  • 15. A study of the methylation status of opioid binding protein/cell adhesion molecule-like gene in ovarian cancer using nested methylation-specific polymerase chain reaction detection.
    Zhou F, Cao X, Liu M, Wang Y, Tao G.
    Clin Lab; 2011 Jul 01; 57(5-6):421-4. PubMed ID: 21755835
    [Abstract] [Full Text] [Related]

  • 16. [*OPCML gene transferred by recombinant lentiviruses in vitro and its inhibition to ovarian cancer cells].
    Yao DS, Li L, Garson K, Vanderhyden BC.
    Zhonghua Fu Chan Ke Za Zhi; 2006 May 01; 41(5):333-8. PubMed ID: 16762191
    [Abstract] [Full Text] [Related]

  • 17. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
    Jiang Y, Tong D, Lou G, Zhang Y, Geng J.
    Pathobiology; 2008 May 01; 75(4):244-51. PubMed ID: 18580070
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. RAS-mediated epigenetic inactivation of OPCML in oncogenic transformation of human ovarian surface epithelial cells.
    Mei FC, Young TW, Liu J, Cheng X.
    FASEB J; 2006 Mar 01; 20(3):497-9. PubMed ID: 16384911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.